Ionis Pharmaceuticals, Inc. (traded on the NASDAQ exchange under the ticker symbol IONS) shares trade at approximately $63.63 per share. Equity values shift continuously throughout active market trading hours based on real-time buying and selling volumes, clinical trial pipeline updates, quarterly earnings reports, and broader biotechnology sector sentiment tracked closely by institutional and retail investors globally.